min on ice and washed twice with FACS buffer (PBS with 2% FBS and 2
mM EDTA buffer). After, cells were fixed and permeabilized with Fix/Perm
buffer (BD Biosciences) for 20 min on ice, washed twice with BD Perm/Wash,
and stained with the intracellular antibodies for 60 min on ice. For PoxP3
staining, cells were fixed and permeabilized with Fix/Perm Buffer
(eBiosciences, San Diego, CA, USA) for 60 min on ice, washed twice with
Perm/Wash buffer (eBiosciences) and stained with intracellular antibodies
for 60 min on ice. Subsequently, the cells were washed twice with the
respective Perm/Wash buffer and kept in 2% paraformaldehyde.
Antibodies used: PBS57-CD1d tet APC (kindly donated by NIH tetramer resource
facility), Vα24 FITC, and CD3 ECD were from Beckman Coulter
(Fullerton, CA), CD4 Qdot655, CD8 Qdot 605, and the viability marker AmCyan
were from Life Technologies (Carlsbad CA, USA), CD25 APC, CD38 PE, HLA-DR
PerCP, IFNγ V450, TNF Alexa700, IL-10 PE, and IL-4 PE-Cy7 were all
from BD bioscience. Data were acquired on a BD LSRFortessa instrument (BD
Biosciences) and analyzed using FlowJo Version 9.8.5 software (TreeStar,
Ashland, OR, USA).